NASDAQ:LGST Semper Paratus Acquisition (LGST) Stock Price, News & Analysis → Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning (From American Hartford Gold Group) (Ad) Free LGST Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.51▼$5.4050-Day Range$4.51▼$4.7852-Week Range$4.08▼$12.03Volume12,500 shsAverage Volume30,930 shsMarket Capitalization$71.35 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesOwnershipShort InterestSocial MediaStock AnalysisHeadlinesOwnershipShort InterestSocial Media Get Semper Paratus Acquisition alerts: Email Address Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. About Semper Paratus Acquisition Stock (NASDAQ:LGST)Semper Paratus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire companies operating in the transportation, supply chain, and logistics industries. Semper Paratus Acquisition Corporation was incorporated in 2021 and is based in New York, New York. Semper Paratus Acquisition Corporation operates as a subsidiary of Ssvk Associates, Llc.Read More Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. LGST Stock News HeadlinesFebruary 14, 2024 | finance.yahoo.comTevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGNFebruary 14, 2024 | globenewswire.comTevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be Listed on Nasdaq Under Ticker TVGNMay 13, 2024 | American Hartford Gold Group (Ad)Rich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.February 1, 2024 | msn.comSPAC Semper Paratus shareholders okay merger with Tevogen BioFebruary 1, 2024 | finance.yahoo.comSemper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen BioJanuary 24, 2024 | finance.yahoo.comSemper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on NasdaqJanuary 10, 2024 | investing.comSemper Paratus Acquisition Corp (LGST)January 5, 2024 | finance.yahoo.comTevogen Bio Inc. and Semper Paratus Acquisition Corporation Announce Effectiveness of Registration Statement for Business CombinationMay 13, 2024 | American Hartford Gold Group (Ad)Rich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.December 5, 2023 | finance.yahoo.comWith a 56% stake, Semper Paratus Acquisition Corporation (NASDAQ:LGST) insiders have a lot riding on the companySeptember 29, 2023 | finance.yahoo.comSemper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing RequirementSeptember 14, 2023 | finance.yahoo.comSemper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio IncJune 30, 2023 | msn.comTevogen to go public via merger with SPAC Semper ParatusJune 29, 2023 | reuters.comBiotech firm Tevogen Bio enters $1.2 bln SPAC deal for US listingJune 27, 2023 | morningstar.comSemper Paratus Acquisition Corp Class AApril 17, 2023 | finance.yahoo.comSemper Paratus Acquisition Corporation (LGST)February 24, 2023 | benzinga.comSemper Paratus Acq Stock (NASDAQ:LGSTU), Trade IdeasJanuary 25, 2023 | wsj.comSemper Paratus Acquisition Corp. Cl AFebruary 18, 2022 | gurufocus.comSaba Capital Management, L.P. Buys FTAC Zeus Acquisition Corp, Semper Paratus Acquisition Corp, ...See More Headlines Receive LGST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Semper Paratus Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:LGST CUSIPN/A CIK1860871 Webwww.semperparatusspac.com Phone646-807-8832FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$4.41 million Net MarginsN/A Pretax MarginN/A Return on Equity-21.83% Return on Assets3.10% Debt Debt-to-Equity RatioN/A Current Ratio0.22 Quick Ratio0.22 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.33 per share Price / Cash Flow13.74 Book Value($1.10) per share Price / Book-4.10Miscellaneous Outstanding Shares15,820,000Free Float6,864,000Market Cap$71.35 million OptionableNot Optionable Beta-0.08 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Surendra K. Ajjarapu (Age 53)CEO & Chairman Mr. Francis Knuettel II (Age 58)M.B.A., Chief Financial Officer Key CompetitorsElutiaNASDAQ:ELUTAtara BiotherapeuticsNASDAQ:ATRATurnstone BiologicsNASDAQ:TSBXInstil BioNASDAQ:TILPrecision BioSciencesNASDAQ:DTILView All CompetitorsInstitutional OwnershipQuarry LPBought 55,000 shares on 2/20/2024Ownership: 0.348%View All Institutional Transactions This page (NASDAQ:LGST) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsNext President (Not Trump. Not Biden.)The Freeport SocietyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semper Paratus Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
